List view / Grid view



20 May 2011 Cephalon logo

Cephalon granted Temporary Restraining Order in AMRIX® patent litigation

20 May 2011 | By Cephalon Inc

The United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon and Eurand for a TRO enjoining Mylan Pharmaceuticals and Mylan from manufacturing, using and selling its cyclobenzaprine hydrochloride extended-release capsules...

18 May 2011 Pfizer logo

Pfizer presents new Phase 3 data

18 May 2011 | By Pfizer

Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival...

18 May 2011 AstraZeneca

Phase II Study Results

18 May 2011 | By AstraZeneca

AstraZeneca announced encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer...